A Diagnostic Approach for Rodent Progressive Cardiomyopathy and Like Lesions in Toxicology Studies up to 28 Days in the Sprague Dawley Rat (Part 2 of 2)

Author:

Hailey James R.1,Maleeff Beverly E.2,Thomas Heath C.3,Pearse Gail4,Klapwijk Jan C.4,Cristofori Patrizia G.4,Berridge Brian2,Kimbrough Carie L.5,Parker George A.6,Morton Daniel7,Elmore Susan8,Hardisty Jerry F.9,Dybdal Noel O.10,Rehagen David A.11,Fikes James D.12,Lamb Martin12,Biddle Kathleen7,Buetow Bernard S.13,Carreira Vinicius14,Nyska Abraham15,Tripathi Niraj K.16,Workman Heather C.17,Bienvenu Jean-Guy18,Brees Ingrid19,Turk James R.20,Adler Rick R.2

Affiliation:

1. Covance Laboratories, Inc., Chantilly, Virginia, USA

2. GlaxoSmithKline, King of Prussia, Pennsylvania, USA

3. Experimental Pathology Laboratories, Collegeville, Pennsylvania, USA

4. GlaxoSmithKline, Ware, Hertfordshire, United Kingdom

5. PAREXEL International, Durham, North Carolina, USA

6. Charles River Laboratories, Durham, North Carolina, USA

7. Pfizer, Groton, Connecticut, USA

8. National Institute of Environmental Sciences, Research Triangle Park, North Carolina, USA

9. Experimental Pathology Laboratories, Research Triangle Park, North Carolina, USA

10. Genentech, Inc., South San Francisco, California, USA

11. MPI Research, Mattawan, Michigan, USA

12. Biogen Idec, Cambridge, Massachusetts, USA

13. Pfizer, San Diego, California, USA

14. Vet Path Services, Inc., Mason, Ohio, USA

15. Sackler School of Medicine, Tel Aviv University, Timrat, Israel

16. Covance Laboratories, Inc., Madison, Wisconsin, USA

17. Covance Laboratories, Inc., Greenfield, Indiana, USA

18. Charles Rivers Laboratories, Montreal, Quebec, Canada

19. Novartis Pharma AG, Basel, Switzerland

20. Amgen, Thousand Oaks, California, USA

Abstract

To test the diagnostic approach described in part 1 of this article, 2 exercises were completed by pathologists from multiple companies/agencies. Pathologist’s examination of whole slide image (WSI) heart sections from rats using personal diagnostic approaches (exercise #1) corroborated conclusions from study #1. Using the diagnostic approach described in part 1, these pathologists examined the same WSI heart sections (exercise #2) to determine whether that approach increased consistency of diagnosis of rodent progressive cardiomyopathy (PCM) lesions. In exercise #2, there was improved consistency of categorization of small borderline morphologies and mild lesions, but a decrement in consistency of categorizing minimal lesions. Exercises 1 and 2 suggest the described diagnostic approach is representative of that in use by the majority of toxicologic pathologists across companies/agencies and that application by all may improve diagnostic consistency of PCM/like lesions. Additionally, a criterion of approximately 5% heart section involvement is suggested for separating mild from moderate or greater severity. While evidence is not absolute, until further investigation shows otherwise, microscopic changes resembling PCM, but located in the epicardial and subepicardial region of the right ventricle, may be considered as part of the spectrum of PCM.

Publisher

SAGE Publications

Subject

Cell Biology,Toxicology,Molecular Biology,Pathology and Forensic Medicine

Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3